Changes in the analgesic mechanism of oxytocin can contribute to hyperalgesia in Parkinsons disease model rats
Nayuka UsamiiD, Hiroharu MaegawaiD, Masayoshi Hayashi, Chiho KudoiD, Hitoshi Niwa
Abstract
Pain is a major non-motor symptom of Parkinsons disease (PD). The alterations in the descending pain inhibitory system (DPIS) have been reported to trigger hyperalgesia in PD patients. However, the underlying mechanisms remain unclear. In the current study, dopaminergic nigrostriatal lesions were induced in rats by injecting 6-hydroxydopamine (6-OHDA) into their medial forebrain bundle. The neural mechanisms underlying changes in nociception in the orofacial region of 6-OHDA-lesioned rats was examined by injecting formalin into the vibrissa pad. The 6-OHDA-lesioned rats were seen to exhibit increased frequency of face-rubbing and more c-Fos immunoreactive (c-Fos-IR) cells in the trigeminal spinal subnucleus caudalis (Vc), confirming hyperalgesia. Examination of the number of c-Fos-IR cells in the DPIS nuclei [including the midbrain ventrolateral periaqueductal gray, the locus coeruleus, the nucleus raphe magnus, and paraventricular nucleus (PVN)] showed that 6-OHDA-lesioned rats exhibited a significantly lower number of c-Fos-IR cells in the magnocellular division of the PVN (mPVN) after formalin injection compared to sham-operated rats. Moreover, the 6-OHDA-lesioned rats also exhibited significantly lower plasma oxytocin (OT) concentration and percentage of oxytocin-immunoreactive (OT-IR) neurons expressing c-Fos protein in the mPVN and dorsal parvocellular division of the PVN (dpPVN), which secrete the analgesic hormone OT upon activation by nociceptive stimuli, when compared to the sham-operated rats. The effect of OT on hyperalgesia in 6-OHDA-lesioned rats was examined by injecting formalin into the vibrissa pad after intracisternal administration of OT, and the findings showed a decrease in the frequency of face rubbing and the number of c-Fos-IR cells in the Vc. In conclusion, these findings confirm presence of hyperalgesia in PD patients, potentially due to suppression of the analgesic effects of OT originating from the PVN.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 1.70
- Field percentile
- top 17%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A novel analgesic pathway from parvocellular oxytocin neurons to the periaqueductal gray
Mai Iwasaki, Arthur Lefèvre, … Alexandre Charlet·bioRxiv·Feb 23, 2022
- Endogenous oxytocin release in periaqueductal gray eases inflammatory pain through long term suppression of pain perception neurons in the spinal cord
Mai Iwasaki, Alexandre Charlet·bioRxiv·Dec 10, 2018
- Inputs to the locus coeruleus from the periaqueductal gray and rostroventral medulla shape opioid-mediated descending pain modulation
Susan T. Lubejko, Giulia Livrizzi, … Matthew R. Banghart·Science AdvancesPeer-reviewed·Apr 26, 2024
- Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion
Andrew J. Flores, Mitchell J. Bartlett, … Torsten Falk·Brain ResearchPeer-reviewed·Dec 1, 2023
- NaV1.7-dependent peripheral sensitization drives chronic pain in Parkinson's disease
Tyler S. Nelson, Naomi K Grabus, … Rajesh Khanna·bioRxiv·Sep 15, 2026
- Effects of the selective dopamine D3 receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice
Christian Alan Botz-Zapp, Stephanie L. Foster, … Daniel F. Manvich·Behavioural Brain ResearchPeer-reviewed·Aug 2, 2021